title: Effects of WIN 55,212-2 on I(K) current in cultured trigeminal ganglion neurons of rat.
abstract: To investigate the effects of WIN 55,212-2 on I(K) in cultured rat trigeminal ganglion (TG) neurons, whole-cell patch clamp techniques were used to record the I(K) before and after WIN 55,212-2 perfusion at different concentrations. 30 micromol/L WIN 55,212-2 markedly (35.7% +/- 7.3%, P < 0.01, n = 8) inhibited I(K) currents, and the currents were partially recovered after washing. 30 micromol/L WIN 55,212-2 also induced a significant depolarizing shift in conductance-voltage parameters (control: V0.5 = 10.43 +/- 4.25 mV, k = 16.27 +/- 3.86; WIN 55,212-2: V0.5 = 24.71 +/- 3.91 mV, k =16.69 +/- 2.75; n = 8, P < 0.01 for V0.5). 0.01 micromol/L WIN 55,212-2 slightly (27.0% +/- 7. 9%, P < 0.05, n = 7) increased I(K) currents, but had no significant change in conductance voltage parameters (control: V0.5 =10.74 +/- 5.27 mV, k = 17.33 +/- 2.96; WIN 55,212-2: V0.5 = 11.06 +/- 2.05 mV, k = 19.69 +/- 6.60; n = 7, P > 0.05 for V0.5 and k). These results suggested that WIN 55,212-2 has dual action, which might be through different receptors.
authors.affiliation: Department of Pharmacology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
authors.forename: Zhangyin
authors.initials: Z
authors.lastname: Ming
authors.forename: Yan
authors.initials: Y
authors.lastname: Tan
authors.forename: Hui
authors.initials: H
authors.lastname: Fu
authors.forename: Xuehong
authors.initials: X
authors.lastname: Cao
authors.forename: Jianping
authors.initials: J
authors.lastname: Pan
authors.forename: Benrong
authors.initials: B
authors.lastname: Hu
authors.forename: Lieju
authors.initials: L
authors.lastname: Liu
authors.forename: Jizhou
authors.initials: J
authors.lastname: Xiang
mesh_terms: D000818:Animals; D048588:Benzoxazines; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D009025:Morpholines / Q000494:pharmacology*; D009281:Naphthalenes / Q000494:pharmacology*; D009474:Neurons / Q000166:cytology / Q000378:metabolism; D024642:Potassium Channels, Voltage-Gated / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012668:Trigeminal Ganglion / Q000166:cytology* / Q000378:metabolism
chemical_list: D048588:Benzoxazines; D002121:Calcium Channel Blockers; D009025:Morpholines; D009281:Naphthalenes; D024642:Potassium Channels, Voltage-Gated; C070417:(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone